Stefanie Mandl

Company: Indapta Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Evaluating Clinical Potential of Different NK Subtypes 2:30 pm

Discuss how different NK subtypes perform against various cancer types and disease models How do different NK phenotypes influence therapeutic outcomes? Is it best to have a homogenous or heterogenous NK product?Read more

day: Day 2 - Track B - PM

Panel Discussion: Exploring Current & Future Opportunities in Entering the Autoimmune Field as an NK Developer 9:00 am

What makes NK applications to the autoimmune space so exciting? Discussing recent advancements that showcase the promise of NK based therapy in autoimmune disease  Evaluating the main hurdles in expanding NKs to the autoimmune space Why is there more funding in autoimmunity than oncology?Read more

day: Pre-Conference Focus Day

Understanding What NKs Look Like in Multiple Sclerosis Patients 1:00 pm

Sharing positive clinical data on NK therapies in autoimmune disease  Analyzing the evidence of NK therapeutic outcomes in patientsRead more

day: Pre-Conference Focus Day